首页> 美国卫生研究院文献>Journal of Visualized Experiments : JoVE >Incorporating Pericytes into an Endothelial Cell Bead Sprouting Assay
【2h】

Incorporating Pericytes into an Endothelial Cell Bead Sprouting Assay

机译:将周细胞掺入内皮细胞珠发芽试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Angiogenesis is the growth of new vessels from pre-existing vasculature and is an important component of many biological processes, including embryogenesis and development, wound healing, tumor growth and metastasis, and ocular and cardiovascular diseases. Effective in vitro models that recapitulate the biology of angiogenesis are needed to appropriately study this process and identify mechanisms of regulation that can be ultimately targeted for novel therapeutic strategies. The bead angiogenesis assay has been previously demonstrated to recapitulate the multiple stages of endothelial sprouting in vitro. However, a limitation of this assay is a lack of endothelial – mural cell interactions, which are key to the molecular and phenotypic regulation of endothelial cell function in vivo. The protocol given here presents a methodology for the incorporation of mural cells into the bead angiogenesis assay and demonstrates a tight association of endothelial cells and pericytes during sprouting in vitro. The protocol also details a methodology for effective silencing of target genes using siRNA in endothelial cells for mechanistic studies. Altogether, this protocol provides an in vitro assay that more appropriately models the diverse cell types involved in sprouting angiogenesis, and provides a more physiologically-relevant platform for therapeutic assessment and novel discovery of mechanisms of angiogenesis regulation.
机译:血管生成是现有血管系统中新血管的生长,是许多生物学过程的重要组成部分,包括胚胎发生和发展,伤口愈合,肿瘤生长和转移以及眼和心血管疾病。需要有效的体外模型来概括血管生成的生物学特性,以适当地研究该过程并确定最终可靶向用于新型治疗策略的调节机制。先前已经证明了珠子血管生成测定法可概括体外内皮发芽的多个阶段。然而,该测定法的局限性在于缺乏内皮-壁细胞相互作用,这是体内内皮细胞功能的分子和表型调节的关键。这里给出的协议提出了一种将壁细胞掺入珠子血管生成测定中的方法,并证明了在体外发芽过程中内皮细胞和周细胞紧密结合。该协议还详细介绍了一种在内皮细胞中使用siRNA有效沉默靶基因的方法,用于机理研究。总而言之,该协议提供了一种体外测定方法,可以更适当地模拟与发芽血管生成有关的多种细胞类型,并为治疗评估和血管生成调节机制的新发现提供更具生理相关性的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号